Change search
ReferencesLink to record
Permanent link

Direct link
Development of quantitative methods for the determination of vemurafenib and its metabolites in human plasma
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, The Institute of Technology.
2014 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Vemurafenib is a potent serine/threonine kinase inhibitor and is registered as Zelboraf® for the treatment of metastatic melanomas harboring BRAFV600E mutations. There is a large individual variation in drug response and the side effects observed among patients treated with Zelboraf® has proven to be severe. 

LC-MS/MS methods were developed to measure vemurafenib and its metabolites in human plasma for prediction of treatment outcome and side effects in order to individualize treatment with Zelboraf®

A novel, rapid quantification method was developed for vemurafenib using a stable isotope labeled internal standard. The method was validated according to international guidelines with regard to calibration range, accuracy, precision, carry-over, dilution integrity, selectivity, matrix effects, recovery and stability. All parameters met the set acceptance criteria. 

The first method suitable for quantifying vemurafenib metabolites in human plasma is presented. Lacking commercially available reference substances, human liver microsomes were used to produce the metabolites. In patient samples at steady-state five previously in vitro identified metabolites were quantified for the first time. 

Place, publisher, year, edition, pages
2014. , 50 p.
Keyword [en]
BRAFV600E, HPLC, Human Liver Microsomes, LC-MS/MS, Melanoma, Metabolites, Vemurafenib
National Category
Medical and Health Sciences Natural Sciences
URN: urn:nbn:se:liu:diva-110076ISRN: LITH-IFM-A-EX— 14/2938—SEOAI: diva2:742665
Subject / course
Chemical Biology
2014-05-27, Linden, Linköping, 13:00 (Swedish)
Available from: 2014-09-03 Created: 2014-09-02 Last updated: 2014-09-03Bibliographically approved

Open Access in DiVA

Development of quantitative methods for the determination of vemurafenib and its metabolites in human plasma(2068 kB)265 downloads
File information
File name FULLTEXT01.pdfFile size 2068 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Strömqvist, Malin
By organisation
ChemistryThe Institute of Technology
Medical and Health SciencesNatural Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 265 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 197 hits
ReferencesLink to record
Permanent link

Direct link